Nutrition and Anabolic Pharmacotherapies in the Care of Burn Patients

Nutrition in Clinical Practice - Tập 29 Số 5 - Trang 621-630 - 2014
Abdikarim Abdullahi1, Marc G. Jeschke2,3,1,4
1Sunnybrook Research Institute, Toronto, Ontario, Canada
2Ross Tilley Burn Centre, Toronto, Ontario, Canada
3Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
4University of Toronto, Toronto, Ontario, Canada

Tóm tắt

Thermal injury is a devastating injury that results in a number of pathological alterations in almost every system in the body. Hypermetabolism, muscle wasting, depressed immunity, and impaired wound healing are all clinical features of burns. Failure to address each of these specific pathological alterations can lead to increased mortality. Nutrition supplementation has been recommended as a therapeutic tool to help attenuate the hypermetabolism and devastating catabolism evident following burn. Despite the wide consensus on the need of nutrition supplementation in burn patients, controversy exists with regard to the type and amount of nutrition recommended. Nutrition alone is also not enough in these patients to halt and reverse some of the damage done by the catabolic pathways activated following severe burn injury. This has led to the use of anabolic pharmacologic agents in conjunction with nutrition to help improve patient outcome following burn injury. In this review, we examine the relevant literature on nutrition after burn injury and its contribution to the attenuation of the postburn hypermetabolic response, impaired wound healing, and suppressed immunological responses. We also review the commonly used anabolic agents clinically in the care of burn patients. Finally, we provide nutrition and pharmacological recommendations gained from prospective trials, retrospective analyses, and expert opinions based on our practice at the Ross Tilley Burn Center in Toronto, Canada.

Từ khóa


Tài liệu tham khảo

American Burn Association.Burn incidence and treatment in the United States: 2012 fact sheet.2012.http://www.ameriburn.org/resources_factsheet.php. Accessed 2012.

10.1007/s10354-009-0651-2

10.1016/j.cps.2009.05.001

10.1007/s002689900071

10.2119/2008-00069.Schwacha

10.1016/S0140-6736(04)16360-5

10.1177/0148607199023003160

10.1016/S0039-6109(16)41029-7

10.1097/00000658-199205000-00011

10.1056/NEJM198708133170702

10.2302/kjm.38.262

10.1210/jc.2012-2599

10.1016/0026-0495(79)90007-6

10.1097/00000658-198708000-00016

Porter C, 2013, Whole body and skeletal muscle protein turnover in recovery from burns, Int J Burns Trauma, 3, 9

Wolfe RR, 1983, Energy metabolism in trauma and sepsis: the role of fat, Prog Clin Biol Res, 111, 89

10.1016/j.burns.2013.03.018

10.1093/ajcn/84.3.475

10.1177/0148607111417446

10.1016/S0749-0704(05)70154-8

10.1210/jc.2008-1947

10.1056/NEJMoa011300

10.1016/j.burns.2004.01.027

10.1016/S0007-1226(97)90507-5

10.1016/S1072-7515(01)01011-0

10.1097/TA.0b013e318265cf87

10.1189/jlb.0212072

Moore FA, 1993, Postinjury multiple organ failure: role of extrathoracic injury and sepsis in adult respiratory distress syndrome, New Horiz, 1, 538

10.1097/00000658-199208000-00002

10.1016/S0305-4179(02)00187-0

10.1007/s00018-012-1152-9

10.1177/0022034509359125

10.1111/j.1524-4725.2008.34254.x

10.12968/jowc.2008.17.9.30937

10.1177/1534734604271810

10.1097/00001432-200404000-00004

10.1097/00005373-200110000-00019

10.2119/molmed.2011.00357

10.1097/SHK.0b013e3181af0494

10.1097/CCM.0b013e3181a40116

10.1016/j.clnu.2013.02.012

10.1016/j.burns.2006.06.014

10.1007/978-3-7091-1133-8

Mullen JL, 1979, Prediction of operative morbidity and mortality by preoperative nutritional assessment, Surg Forum, 30, 80

10.1016/j.jaci.2005.04.036

10.1007/s00134-005-2727-9

10.1097/BCR.0b013e3181eebf01

10.1097/01.ccx.0000216582.87674.a4

10.1079/PNS19980056

10.1016/j.burns.2005.11.020

10.1093/jn/131.9.2543S

10.1097/00003246-200111000-00006

10.1177/0148607104028002123

10.1097/01.CCM.0000084848.63691.1E

Appleton J, 2002, Arginine: clinical potential of a semi‐essential amino, Altern Med Rev, 7, 512

10.1016/j.burns.2006.06.012

Yu YM, 1996, Kinetics of plasma arginine and leucine in pediatric burn patients, Am J Clin Nutr, 64, 60, 10.1093/ajcn/64.1.60

10.1097/00003246-199503000-00006

10.1016/j.nut.2006.03.009

Gamliel Z, 1996, Essential microminerals and their response to burn injury, J Burn Care Rehabil, 17, 264

10.1016/j.jada.2004.03.020

10.1097/BCR.0b013e31824d1c2c

Klein GL, 2006, Burn‐induced bone loss: importance, mechanisms, and management, J Burns Wounds, 5, e5

10.1016/j.nut.2006.06.004

10.1093/ajcn/85.5.1301

10.1093/ajcn/85.5.1293

10.1016/j.jtemb.2007.09.013

10.1097/01.ta.0000198552.34139.46

10.1097/00000658-199509000-00007

10.1097/01.CCM.0000278065.72486.31

10.1097/00000658-199901000-00002

10.1152/ajpendo.1977.232.4.E415

10.1097/00005373-200010000-00015

10.1097/00005373-200109000-00021

10.1097/00003246-200211000-00006

10.1210/en.2004-0592

10.1097/01.sla.0000118569.10289.ad

10.1097/00005373-199802000-00019

10.1517/14656566.2012.738195

10.1056/NEJMoa070716

10.1186/cc12678

Jeschke MG, 2010, Glucose control in severely thermally injured pediatric patients: what glucose range should be the target?, Ann Surg, 252, 521, 10.1097/SLA.0b013e3181f2774c

10.1016/S1096-6374(98)80033-6

Boulware SD, 1992, Diverse effects of insulin‐like growth factor I on glucose, lipid, and amino acid metabolism, Am J Physiol, 262, E130

Strock LL, 1990, The effect of insulin‐like growth factor I on postburn hypermetabolism, Surgery, 108, 161

10.1097/00000658-199905000-00014

10.1002/dmrr.538

10.1053/j.gastro.2007.03.054

10.1016/j.amjmed.2009.03.012

10.1172/JCI116186

10.1186/cc7874

10.1677/joe.0.1550369

10.1186/cc9222

10.1097/01.ta.0000180387.34057.5a

10.1056/NEJM199508313330903

10.1016/j.resuscitation.2003.08.003

10.1097/01.sla.0000152013.23032.d1

10.1097/00000658-197909000-00002

10.2165/00003495-200363180-00001

10.1097/01.TA.0000026990.32856.58

10.1136/bmj.39255.669444.AE

10.1016/j.burns.2013.04.002

10.1097/00000658-200104000-00012

10.1053/jcrc.2000.0150012

10.1046/j.1524-475x.2000.00097.x

10.1002/cpt1973145862

10.1097/01.BCR.0000202620.55751.4F

10.1097/SLA.0b013e318146980e

10.1097/01.sla.0000137131.22608.e2

10.1097/SLA.0b013e318265427e

10.1056/NEJMoa010342

10.1097/00000658-199606000-00016

10.1097/00000658-198810000-00010

10.1186/1743-7075-4-9